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ABSTRACT
Objectives: The study aims to apply willingness-to-pay (WTP) values
derived from the literature to inform decision-makers of the cost-
effectiveness of the Tailored Activity Program (TAP), an intervention
proven to reduce caregiver burden.
Methods: TAP and other caregiver interventions employ an individual
perspective and non–quality-adjusted life-year (QALY) outcome measure
where the primary objective is to determine caregiver burden from an
individual perspective. Therefore, standard cost/QALY thresholds are not
appropriate. To identify relevant WTP values, we searched for studies that:
1) were published in the past 5 years and used contingent valuation
methodology to identify WTP; 2) assessed WTP for a dementia-related
intervention requiring out-of-pocket expenditure; and 3) asked caregivers
their WTP for an outcome related to reducing caregiver burden. Three
studies were identiﬁed utilizing four WTP values. We also assessed poten-
tial ﬁnancial savings that caregivers could achieve from purchasing TAP.
To assess the probability of TAP being cost-effective, we built a Monte
Carlo simulation to test the four WTP values applied to two TAP
outcome measures: reduction in caregiver hours “on duty;” and “doing
things.”
Results: For outcome measure “on duty,” WTP varied between $1.06/
hour and $4.58/hour. For outcome measure “doing things,” WTP varied
between $2.21/hour and $9.57/hour. Applying the four identiﬁed WTP
values from the literature to TAP outcomes resulted in TAP cost-
effectiveness varying between 50% and 80% for both outcome measures.
Conclusions: When WTP data are not collected prospectively or conven-
tional metrics cannot be applied, retrospectively assessing literature-
derived WTP may be acceptable for informing decision-makers of
potential cost-effectiveness of a proven program. Application of WTP to
TAP shows potential cost-effectiveness that can be expected under the
tested WTP scenarios.
Keywords: Alzheimer’s disease, contingent valuation method, outcomes of
mental health care, willingness-to-pay.
Introduction
Dementia is one of the most costly diseases in the United States
with a total annual cost to society estimated to be $152 billion
[1]. Dementia is also ﬁnancially debilitating for patients and their
family caregivers. The largest portion of dementia costs is asso-
ciated with time spent caregiving by family members, reﬂecting
an estimated aggregate cost of $97 billion. This equates to
$40,000 a year that an individual family spends in caring for a
relative with dementia [2]. Costs incurred by family caregivers
include direct out-of-pocket expenses and/or, informal costs
(unpaid help or lost income by family members) [1] and lost
productivity. Neuropsychiatric behaviors are a common clinical
symptom of dementia that increase the amount of time required
to provide care and hence caregiver burden and cost [3,4].
Although the optimal treatment to address behavioral symp-
toms and reduce caregiver burden is unclear, emerging nonphar-
macological approaches appear promising [5–7]. Yet, for
nonpharmacologic interventions to become part of the standard
of care for dementia patients, economic evaluations are needed to
determine their value to society and individuals [8]. At the indi-
vidual level, economic evaluations are needed to determine the
willingness-to-pay (WTP) for different effective caregiver inter-
ventions. Although there are now many proven caregiver
interventions, to date, few incorporate an economic evaluation
[9,10]. Of those studies that have evaluated cost-effectiveness,
most have not determined caregiver WTP, making it difﬁcult to
assess how individuals value these interventions [8]. The need to
offer proven interventions to reduce the burden of family car-
egivers and understand their economic value is underscored by it
becoming an explicit priority goal of Health People 2020 [11].
Lack of WTP data also makes it difﬁcult to compare eco-
nomic outcomes across caregiver programs or with other health
services. Thus, identifying WTP levels appropriate for economic
analyses of these proven programs that are from an individual
caregiver perspective is an important methodological step. Such
an approach may help to advance economic evaluations and the
translation of dementia caregiver programs for delivery in diverse
service settings.
Most economic evaluations of health services utilize a stan-
dard societal threshold of less then $50,000/quality-adjusted
life-year (QALY) as a measure of cost-effectiveness [12]. Never-
theless, when a QALY is not employed as the outcome measure,
it is not possible to compare cost-effectiveness to the $50,000
threshold. There have also been several studies that question the
validity of applying a standard $50,000 threshold. These studies
suggest that WTP should be tailored to individual preferences
[13,14].
Moreover, when assessing interventions for dementia caregiv-
ers, a societal perspective that employs QALYs may not be
appropriate. Traditional methodologies to capture QALYs focus
on mobility and physical and emotional functioning. Neverthe-
less, they do not address the quality of life challenges experienced
by families such as the increasing amount of time required to
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attend to dementia patients [8,15]. Guidelines for health eco-
nomic methods suggest that studies should select outcome mea-
sures and perspectives that are most relevant to the patient
population rather than apply a standard metric [16]. As respite
or time to self is a highly valued commodity by caregivers, time
spent caregiving serves as an appropriate, targeted outcome [9].
Currently, caregiver interventions are not supported by third
party payers and thus may need to be purchased out-of-pocket.
Thus, applying an individual perspective using contingent valu-
ation to evaluate the Tailored Activity Program (TAP) is appro-
priate [17]. Determining a caregiver’s WTP based on the clinical
and economic metrics which are important to this population is
vital for informing decision-makers [18–20].
The purpose of this exploratory study was to apply different
caregiver-based WTP values to evaluate retrospectively the cost-
effectiveness and ﬁnancial savings of a proven nonpharmacologic
intervention, the TAP.
TAP, an 8-session, 4-month structured occupational therapy
intervention, provides dementia patients with activities tailored
to their capabilities, and trains family caregivers in their use.
Speciﬁcally, occupational therapists assess the cognitive function-
ing and preserved capabilities of individuals with dementia
including their previous and current interests and daily activities,
caregiver communication style, and the physical home environ-
ment. Based on this assessment, therapists develop activities to
match patient interests and capabilities and then instruct caregiv-
ers in their use, including how to set up the environment, intro-
duce and supervise the activity, and communicate and cue
effectively. As reported elsewhere, TAP was shown to reduce
behavioral occurrences and increase activity engagement of
dementia patients. It also beneﬁted caregivers by enhancing their
sense of conﬁdence using activities in daily routines and reducing
the time required in daily oversight or vigilance [21,22]. In a
previous cost-effectiveness study, we showed that the cost to
reduce 1 hour of the caregiver “doing things” for the patient per
day was $2.37, and the cost to reduce 1 hour of the caregiver
having to be “on duty” was $1.10 [23]. This exploratory study
extends our cost-effectiveness analysis by evaluating four differ-
ent WTP scenarios and examining the potential ﬁnancial savings
caregivers may achieve by purchasing the TAP intervention.
Methods
Study Sample
The WTP analysis was applied to the original TAP trial and
cost-effectiveness analysis. The original TAP trial consisted of a
two-group randomized parallel design in which 60 dyads
(dementia patients/caregivers) were recruited between 2005 and
2006 and randomly assigned to treatment or wait-list control
[21,22]. At 4-months (main trial end point) from baseline, all
dyads were interviewed and reassessed on study outcomes.
The characteristics of study participants have been previously
reported [21,22]. Brieﬂy, to participate in TAP, dementia patients
had to be English speaking, have a physician diagnosis or Mini-
Mental State Examination score less than 24 [24], and have one
or more behavioral symptoms as reported by caregivers. Caregiv-
ers had to be English-speaking, 21 years of age or older, living
with patients, and providing four or more hours of care daily.
Outcome Measures
We used two caregiver-time related items as outcomes (hours
spent “on duty” and hours spent “doing things”) from the 4-item
Caregiver Vigilance Scale [25]. The two other items (how long
patient can be left at home alone in an emergency, and how long
patient can be left in a room alone if someone is home) were not
used in the original TAP trial as they do not measure caregiver
time in daily care. Each item on the scale can be used indepen-
dently and has been shown to have content validity [25]. Addi-
tionally, two recent studies provide further evidence of the
construct validity of the two independent vigilance items used in
this study [9,26]. Nichols and colleagues found a treatment effect
for “doing things,” and Gitlin and colleagues found a treatment
effect for “on duty.”
Data Sources forWTP Values
To determine different WTP levels to apply to TAP, we identiﬁed
three published studies involving four WTP values that were
conducted in the past 5 years and that ﬁt these criteria: 1) used
contingent valuation methodology to identify WTP; 2) assessed
WTP for a dementia-related intervention that required an out-
of-pocket expenditure; and 3) asked caregivers what they would
be willing to pay for an outcome of either stabilizing dementia or
reducing caregiver burden.
We only included studies speciﬁc to dementia caregivers
versus studies of informal caregiving in general for several
reasons. Caring for an individual with dementia is one of the
most profoundly disturbing and time-consuming forms of car-
egiving. Compared to caregivers of individuals with nondement-
ing conditions, dementia caregivers are more distressed and pay
higher out-of-pocket expenses [27]. Thus, we reasoned that WTP
values derived from informal caregiving studies in general would
not adequately reﬂect valuations of dementia caregivers.
One study, conducted by Chiu et al., interviewed 136 family
caregivers of patients with dementia to determine the maximum
amount they would be willing to pay in a month for nursing
home services [28]. A second study by Werner et al. used an
open-ended question to determine the amount of money 220
caregivers would be willing to pay in a month to purchase a
medication that controls dementia [29]. The third identiﬁed
study by Wu et al. sought to determine the WTP of 28 caregivers
for a cholinesterase inhibitor for mild to moderate dementia [30].
Although Wu et al. presented four outcome scenarios, only two
were relevant and used here. The two relevant scenarios sought
to determine WTP for stabilizing dementia, similar to the
purpose of the TAP intervention, whereas the other two scenarios
not used here addressed curative interventions for dementia
(Table 1).
All WTP monetary values taken from the literature were
adjusted to 2008 US dollars (USD) [31]. For studies which pre-
sented results in foreign currency, currency conversion (foreign
currency to USD) rates were taken from the ﬁrst of the month of
the publication date of the study [32].
Data Analysis
AdjustedWTP Values
Because the original TAP trial evaluated the two outcome mea-
sures of caregiver time on a per hour basis, we adjusted WTP
levels used in the selected studies to reﬂect a unit value per hour.
To adjust WTP values on a per hour basis for each measure, we
derived a daily WTP estimate (based on the time frame in the
published study) and then divided the per day estimate by the
average beneﬁt the TAP intervention delivered in a day for each
outcome measure. The mean amount of beneﬁt purchased in a
day for the outcome measure “on duty” was 6.9 hours and for
the outcome measure time spent “doing things” was 3.3 hours
[21,22]. We derived the mean beneﬁt in a day that a caregiver
could purchase based on the original TAP study outcomes as they
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equate to the average beneﬁt the intervention group derived over
the control group for each outcome measure. Finally, we assumed
that an individual would be able to purchase caregiver time in
increments of 1 hour.
Financial Savings as a Measure ofWTP
We also evaluated WTP from the perspective of the potential
ﬁnancial savings caregivers may achieve from purchasing the
TAP intervention. When evaluating WTP values of TAP based on
ﬁnancial savings a caregiver could achieve by participating in the
intervention, we assumed that the value of 1 hour of time for a
family caregiver was equal to the federal minimum wage of $7.25
[33]. We assumed an individual would be willing to purchase
TAP as long as the cost of the intervention did not exceed the
value of time saved per hour.
Monte Carlo Simulation
To evaluate the probability of TAP being cost-effective given
varying WTP thresholds, we constructed a decision tree using
TreeAge Pro 2009 (Williamstown, MA). Our model inputs for
the TAP decision tree were taken from our previously published
cost-effectiveness study of TAP [23] and included seven model
inputs (training, caregiver time, assessment materials, interven-
tion supplies, interventionist time, travel time, mileage reim-
bursement), accounting for the cost of delivering and
implementing TAP. To account for variability in the TAP decision
tree model and assess probability of TAP being cost-effective
based on varying WTP values and ﬁnancial savings analysis, we
conducted a second order Monte Carlo simulation. All model
inputs needed for the Monte Carlo sensitivity analysis were
derived from the previous TAP cost-effectiveness study. Mean
and standard deviations were used to account for variability.
We ran 10,000 iterations through the Monte Carlo simula-
tion for both outcome measures. Acceptability curves were
derived for each outcome measure and used to asses the prob-
ability of TAP being cost-effective based on varying WTP levels.
Results
Sample Characteristics
Table 1 details the demographic characteristics of each study
including the TAP study sample. In the TAP study, most dementia
patients were male (57%) and white (77%) with a mean age of
79 (SD 9.4) years and MMSE score of 11.6 (SD 8.1) [24]. The
majority of caregivers were female (88%) and white (77%) with
a high school diploma (56%), and average age of 65 (SD 11.1)
years. Caregivers reported managing many behavioral symptoms
(Mean = 8; SD 3.8) and a high number of functional dependen-
cies (Mean = 7.8; SD 0.5). On average, caregivers spent 6.25 (SD
3.81) hours of their time doing things for patients and 16.85 (SD
7.54) hours providing direct oversight or “being on duty.” At
baseline, there were no statistically signiﬁcant differences
between the wait-list control and TAP intervention groups except
for caregiver age. Caregivers in the TAP group were on average 5
years younger than those in the control group.
Table 1 also shows the basic demographic characteristics of
patients in those studies which were used to derive the WTP
comparisons. Similar to the TAP sample, the majority of caregiv-
ers in the three studies were female and less than 65 years old.
Most dementia patients were men and greater than 65 years old.
AdjustedWTP Values
Table 2 details the estimated per hour WTP of each study for
both outcome measures. Adjusted WTP values from Chiu et al.
Table 1 Demographics of study samples included in cost analyses
Study N (dyads)
Caregivers Patients with dementia
Age Sex Age Sex Cognitive status
Mean (SD) % Female Mean (SD) % Female Mean MMSE (SD)
Gitlin et al. [22] 60 65 (11.1) 88 79 (9.4) 43 12 (8.1)
Chiu et al. [28] 136 <65 = 67.6%* 73.5 <65 = 20% 44.9 65.5% Mild-Moderate MMSE†
Werner et al. [29] 220 62* 68.2 73.4* 50.9 17.1*
Wu et al. [30] 28 66 (14.32) 75 78.29 (4.31) 32 Mild-Moderate MMSE†
*Study did not publish SD.
†Numeric MMSE scores not published.
MMSE, Mini Mental State Examination; SD, Standard Deviation.
Table 2 Adjusted willingness to pay values and probability of cost-effectiveness
Study Intervention
WTP per
intervention ($)
Estimated WTP per hour ($) % of time TAP cost-effective
On duty Doing things On duty Doing things
Chiu et al. [28] Caregivers asked amount willing to pay in a month to
receive nursing home services.
978 4.58 9.57 80 70
Werner et al. [29] Caregivers asked amount willing to pay in a month for a
drug treatment.
225 1.06 2.21 50 50
Wu et al. [30] Caregivers asked amount willing to pay to stabilize patient
over 1 year in both cognition and behavior with a
cholinesterase inhibitor treatment.
4224 1.68 3.51 60 60
Wu et al. [30] Caregivers asked amount willing to pay to stabilize over 1
year in both cognition and behavior with a
cholinesterase inhibitor treatment; however, with
adverse events.
3788 1.50 3.14 60 60
All studies used contingent valuation methodology.
WTP, willingness-to-pay.
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[28] were $4.58 (“on duty”) and $9.57 (“doing things”). For
Werner et al. [29], WTP values were adjusted to $1.06 (“on
duty”) and $2.21 (“doing things”). Finally, for Wu et al. [30],
WTP was adjusted to $1.68 (“on duty”) and $3.51 (“doing
things”) for a cholinesterase inhibitor.
Financial Savings as a Measure ofWTP
For the outcome measure “on duty,” we estimated that the TAP
intervention saved on average $50 a day or $6003 over the
course of the intervention ($7.25 ¥ 6.9 hours of time saved on
average a day ¥ 120 days). Similarly, for the outcome measure
“doing things,” we estimated that TAP saved on average $24 a
day or $2872 over the course of the intervention ($7.25 ¥ 3.3
hours of time saved on average a day from TAP trial ¥ 120 days).
Monte Carlo Simulation
Figure 1 shows the acceptability curves from the Monte Carlo
simulation for each outcome measure, “on duty” and “doing
things.” For both outcome measures, WTP was assessed on a
per hour basis. The acceptability curve serves as a visual repre-
sentation of the Monte Carlo simulation. The x-axis represents
a range of WTP values per hour. The y-axis represents the
probability of TAP being cost-effective for intervention group
caregivers.
For the outcome measure “on duty,” the point at which TAP
had a 50% probability of being cost-effective is equal to a WTP
of $1.20 an hour. At any WTP level greater than $1.20 for the
outcome measure “on duty,” the probability of TAP being cost-
effective was greater than 50%. Similarly, for the outcome
measure “doing things,” TAP had a 50% probability of being
cost-effective given a WTP of $2.40 an hour. At any WTP value
greater than $2.40 for the outcome measure “on duty,” the
probability of TAP being cost-effective was greater than 50%.
WTP Comparisons
Table 2 also details the probability of TAP being cost-effective for
each outcome measure based on the four estimated per hour
WTP values. Using the WTP levels derived from Chiu et al. [28],
we found that TAP had an 80% probability of being cost-
effective for the measure “on duty” and 70% probability for the
measure “doing things.” Based on the WTP values derived by
Werner et al. [29], we estimated that TAP had a 50% probability
of being cost-effective for both outcome measures. Finally, based
on the WTP values from Wu et al. [30], we estimated that for
both outcome measures, TAP had a probability of being cost-
effective 60% of the time. Based on our assumptions for the
ﬁnancial savings analysis, we found that for both outcome mea-
sures (“on duty” and “doing things”), TAP had an 80% prob-
ability of being cost-effective.
Discussion
There is a dearth of published literature on WTP thresholds and
cost-effectiveness for nonpharmacologic dementia interventions
from an individual caregiver perspective. Generally, cost-
effectiveness analyses employ a societal threshold of $50,000/
QALY; however, when studies employ non-QALY outcome
measures and use nonsocietal perspectives, standard conventions
cannot be applied [12,13]. Others have argued that traditional
cost-effectiveness thresholds such as the $50,000/QALY are arbi-
trary and as such do not allow for a true valuation of an inter-
vention [14,17]. In our analysis, we adopted WTP thresholds
that were not arbitrary but rather represented a composite of
WTP values derived via contingent valuation from previously
published studies. Contingent valuation methodology has been
validated in several studies [34,35] and is an acceptable approach
to value informal care. As such, the WTP values derived from the
literature on dementia caregivers serve as the best proxy for the
market price and subsequently, the value of TAP.
To date, there is no consensus in the health economic litera-
ture as to how to value informal care in economic analyses [36].
The analyses presented here are novel in that we incorporated
time spent caregiving as the outcome measures rather than as a
cost. TAP uses an individual perspective and employs two mea-
sures (“on duty” and “doing things”) of caregiver time which is
a highly salient commodity to families. Nevertheless, typically,
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when valuing interventions in health economics, elements of an
intervention pertaining to time are considered part of the cost
variables. By incorporating time as an outcome measure rather
than in the cost component of the analysis, we are able to avoid
ambiguities with valuing time [36]. Instead, time is valued in our
analysis via WTP values derived from contingent valuation.
We believe that these time-based outcome measures, also used
in previous caregiver cost analysis studies [9,25,27], are the most
clinically relevant and as such should be used as the primary
outcome measures when determining WTP for caregiver pro-
grams. In addition, we believe that if individuals were to pur-
chase the TAP intervention on their own, they would do so on the
merits of it reducing time spent caregiving and not on their
QALY beneﬁts.
Using WTP thresholds previously reported in research on
caregiver preferences, we were able to estimate the probability of
TAP being cost-effective [28–30]. All WTP values from the lit-
erature were greater than $1.06 for the outcome measure “on
duty” and greater than $2.20 for the outcome measure “doing
things.” As such, given the baseline cut points for cost-
effectiveness, TAP compares favorably to the WTP values from
the literature. For the outcome measure “on duty,” we found that
for any WTP greater than $1.20 an hour, TAP has a greater than
50% chance of being cost-effective. Similarly for the outcome
measure “doing things,” we found that for any WTP greater than
$2.40 an hour, TAP is cost-effective greater than 50% of the time.
Although this appears to be a positive result, it is not possible to
compare this to other studies because of a lack of published
literature on WTP for caregiver interventions.
Some health economic researchers have argued that WTP
metrics are static and do not provide adequate information over
time [14]. Nevertheless, the use of acceptability curves can
accommodate this shortcoming [14,37]. Given the individual
perspective of our study, the acceptability curve can be used by
the individual decision-maker who is able to account for his/her
own WTP as it may change over time.
The ﬁnancial savings analysis is comparable to an opportu-
nity cost analysis [34]. Although opportunity cost analyses have
been critiqued when presented on their own, when part of an
overall valuation such as our analysis, it provides additional
information for the decision-maker. The ﬁnancial savings analy-
sis showed that TAP was cost-effective 80% of the time. This
analysis assumes that caregivers would be able to replace time
spent caregiving with a wage-earning activity. This may be a
limitation of our study as it places a monetary value on time,
even when caregivers may choose to spend their newfound time
differently than earning real cash wages. Nevertheless, for many
caregivers, the opportunity for respite during the day is an
invaluable commodity which is not easy to achieve, particularly
caring for individuals at the moderate and severe disease stages
when hands-on care and heightened vigilance are required
[38,39]. As such, we believe that the ﬁnancial savings analysis
may understate the value of time gained given the assumptions in
our model and the moderate hourly wage we employed. It should
be noted that TAP resulted in caregivers having extra time by
meaningfully engaging the individual with dementia in safe and
pleasant activities. Thus, TAP enhanced the quality of life of the
individual with dementia, and the caregiver’s time away from
caregiving did not compromise the safety or well-being of the
dementia patient. Also, it should be noted that at baseline there
was a 5-year age difference with those assigned to TAP being
younger than those in the control group. Younger caregivers may
be more likely to work and thus value their time more as it might
represent lost income. Thus, TAP may have been more cost-
effective than the data show.
Several limitations should be noted. As we did not capture
WTP values prospectively in the initial TAP trial, we necessarily
had to rely on WTP values derived from studies that evaluated
different although similar treatments. There are numerous
factors that can lead to inconsistency when applying different
WTP thresholds derived from other studies including social
norms/values, and different methodologies used to elicit WTP.
Nevertheless, the studies we chose had comparable treatments in
that they valued outcomes of dementia-related interventions
similarly. In addition, using multiple studies render our WTP
analysis more robust than selecting one study and applying a
single value from the literature.
Another potential study limitation is the adjustment of the
WTP thresholds to reﬂect a per hour basis so that a comparison
could be made to TAP. We assumed that when adjusting WTP on
a per hour basis, there would be consistency and reliability
between published values and adjusted values. Again, we also
addressed this limitation by using four different WTP thresholds
derived from the literature. Finally, another limitation may be
our assumption that TAP can be purchased in increments of 1
hour. For example, individual caregivers cannot deliberately
choose to purchase 6.9 hours of less time spent being “on duty.”
Although we recognize this argument, we selected 1-hour incre-
ments because of ease of use when conducting such a micro
economic analysis. Furthermore, this level of analysis also ben-
eﬁts decision-makers who can then use this most basic unit of
measurement and adjust to a level they believe to be appropriate.
Despite these limitations, we believe that WTP analyses are at
the forefront of evaluating cost-effectiveness of existing caregiver
programs from an individual perspective. In addition, our ﬁnd-
ings help to demonstrate the value of informal caregiving and
offer insight in understanding the needs of caregivers [8,11].
Most importantly, our ﬁndings from this exploratory study illus-
trate a method to evaluate cost-effectiveness when WTP data are
not collected prospectively and standard WTP metrics cannot be
used. To our knowledge, this is the ﬁrst study which shows that
it is possible to use previously reported relevant WTP levels and
apply these values to a similar study in an effort to inform
decision-makers of potential cost-effectiveness. We show the fea-
sibility of assessing WTP retrospectively via two approaches.
First, by using comparable WTP thresholds in the literature, and
secondly, by assessing the potential ﬁnancial savings one may
achieve from partaking in the intervention [34,35]. As such, this
study adds incrementally to the health economic literature and
highlights the value of evaluating caregiver interventions to sub-
stantiate their translational potential.
In summary, this study lends further support to the economic
value of TAP. It also shows the value of applying WTP scenarios
retrospectively, offering an exploratory methodology to evaluate
and compare existing proven caregiver programs.
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